News

Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood ...
The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.
The FDA has approved Gamifant as the first-ever treatment for macrophage activation syndrome in Still’s disease for adults ...
The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval ...
Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...
The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...
The FDA approved Lynozyfic for relapsed multiple myeloma, but serious risks require restricted use under a special safety program.
With the FDA recently rejecting a drug application that aims to help those living with Barth Syndrome, one Bay Area family is ...
The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...
A common drug used for inflammatory skin conditions may hold the key to treating both alcohol addiction and pain sensitivity.
The generic drug contains cefovecin sodium, the same active ingredient in Convenia (Zoetis Inc), which was approved by the ...